{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:34:37Z","timestamp":1792787677280,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jamda.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jamda.2020.09.046","type":"journal-article","created":{"date-parts":[[2020,12,13]],"date-time":"2020-12-13T08:41:57Z","timestamp":1607848917000},"page":"15-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["The Use and Misuse of Proton Pump Inhibitors: An Opportunity for Deprescribing"],"prefix":"10.1016","volume":"22","author":[{"given":"Thiruvinvamalai S.","family":"Dharmarajan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2020.09.046_bib1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.giec.2019.12.005","article-title":"Proton pump inhibitors. The good, bad and ugly","volume":"30","author":"Schnoll-Sussman","year":"2020","journal-title":"Gastrointest Endoscopy Clin N Am"},{"key":"10.1016\/j.jamda.2020.09.046_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5009\/gnl15502","article-title":"25 years of proton pump inhibitors: A comprehensive review","volume":"11","author":"Strand","year":"2017","journal-title":"Gut Liver"},{"key":"10.1016\/j.jamda.2020.09.046_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejim.2016.10.007","article-title":"The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal","volume":"37","author":"Savarino","year":"2017","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jamda.2020.09.046_bib4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12916-017-0804-x","article-title":"When is proton pump inhibitor use appropriate?","volume":"15","author":"Yadlati","year":"2017","journal-title":"BMC Med"},{"key":"10.1016\/j.jamda.2020.09.046_bib5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12916-016-0718-z","article-title":"Effective and safe proton pump inhibitor therapy in acid-related diseases \u2013 A position paper addressing benefits and potential harms of acid suppression","volume":"14","author":"Scarpignato","year":"2016","journal-title":"BMC Med"},{"issue":"2Supp 1","key":"10.1016\/j.jamda.2020.09.046_bib6","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0016-5085(00)70004-7","article-title":"Acid suppression: Optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease and stress related erosive syndrome","volume":"118","author":"Wolfe","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jamda.2020.09.046_bib7","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/17425255.2018.1461835","article-title":"Proton pump inhibitors: From CYP2C19 pharmacogenetics to precision medicine","volume":"14","author":"Rouby","year":"2018","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.jamda.2020.09.046_bib8","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.cll.2014.08.008","article-title":"The impact of proton pump inhibitor on the human gastrointestinal microbiome","volume":"34","author":"Freedberg","year":"2014","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.jamda.2020.09.046_bib9","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.3748\/wjg.v25.i22.2706","article-title":"Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified","volume":"25","author":"Bruno","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jamda.2020.09.046_bib10","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jamda.2014.07.001","article-title":"Medications, renal function and kidney injury: A complex interplay, wherein prevention is easier than cure!","volume":"15","author":"Dharmarajan","year":"2014","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2020.09.046_bib11","series-title":"Obesity and Disease in an Interconnected World: A Systems Approach to Turn Huge Challenges into Amazing Opportunities","first-page":"281","article-title":"Prescribing medications for older adults: Dealing with obesity, misuse, polypharmacy and adverse drug events","author":"Dharmarajan","year":"2015"},{"key":"10.1016\/j.jamda.2020.09.046_bib12","doi-asserted-by":"crossref","first-page":"7591045","DOI":"10.1155\/2019\/7591045","article-title":"Predictors of inappropriate proton pump inhibitors use in elderly patients","volume":"2019","author":"Voukelatou","year":"2019","journal-title":"Curr Gerontol Geriatr Res"},{"key":"10.1016\/j.jamda.2020.09.046_bib13","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1111\/jgs.16117","article-title":"Low-value proton pump inhibitor prescriptions among older adults at a large academic health system","volume":"67","author":"Mafi","year":"2019","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2020.09.046_bib14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4137\/CGast.S9588","article-title":"Proton pump inhibitor us in hospitalized patients: Is overutilization becoming a problem","volume":"5","author":"Durand","year":"2012","journal-title":"Clin Med Insights Gastroenterol"},{"key":"10.1016\/j.jamda.2020.09.046_bib15","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s40265-017-0712-6","article-title":"The safety of appropriate use of over-the-counter proton pump inhibitors: An evidence-based review and Delphi consensus","volume":"77","author":"Johnson","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.jamda.2020.09.046_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1756284820913743","article-title":"Long-term use of proton-pump inhibitors: whole-of-population patterns in Australia 2013\u20132016","volume":"13","author":"Daniels","year":"2020","journal-title":"Ther Adv Gastroenterol"},{"key":"10.1016\/j.jamda.2020.09.046_bib17","first-page":"1","article-title":"Proton-pump inhibitors among adults: a nationwide drug-utilization study","volume":"11","author":"Halfdanarson","year":"2018","journal-title":"Ther Adv Gastroenterology"},{"key":"10.1016\/j.jamda.2020.09.046_bib18","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2147\/TCRM.S81759","article-title":"Evaluation of costs accrued through inadvertent continuation of hospital-initiated proton pump inhibitor therapy for stress ulcer prophylaxis beyond hospital discharge: A retrospective chart review","volume":"11","author":"Shin","year":"2015","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.jamda.2020.09.046_bib19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jamda.2012.10.018","article-title":"Prevalence and associations of the use of proton-pump inhibitors in nursing homes: A cross-sectional study","volume":"14","author":"de Souto Barreto","year":"2013","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2020.09.046_bib20","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2017.01.031","article-title":"The risks and benefits of long-term use of proton pump inhibitors: Expert Review and Best Practice Advice from the American Gastroenterological Association","volume":"152","author":"Freedberg","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jamda.2020.09.046_bib21","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s00228-019-02692-3","article-title":"Proton pump inhibitors: Why this gap between guidelines and prescribing practices in geriatrics?","volume":"75","author":"Michelon","year":"2019","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jamda.2020.09.046_bib22","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/j.1365-2036.2009.03935.x","article-title":"Adherence to best practice guidelines in dyspepsia: a survey comparing dyspepsia experts, community gastroenterologists and primary care providers","volume":"29","author":"Spiegel","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jamda.2020.09.046_bib23","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jamda.2007.10.004","article-title":"Do acid-lowering agents affect vitamin B12 status in older adults?","volume":"9","author":"Dharmarajan","year":"2008","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2020.09.046_bib24","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/jgs.12826","article-title":"Proton pump inhibitors and functional decline in older adults discharged from acute care hospitals","volume":"62","author":"Corsonello","year":"2014","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2020.09.046_bib25","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13054-016-1305-6","article-title":"Efficacy and safety of proton pump inhibitors for stress ulcer prophylaxis in critically ill patients: A systematic review and meta-analysis of randomized trials","volume":"20","author":"Alshami","year":"2016","journal-title":"Crit Care"},{"key":"10.1016\/j.jamda.2020.09.046_bib26","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.3748\/wjg.v23.i35.6500","article-title":"Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis","volume":"23","author":"Trifan","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jamda.2020.09.046_bib27","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1053\/j.gastro.2019.05.056","article-title":"Safety of proton pump inhibitors based on a large, multi-year, randomized trial of patients receiving rivaroxaban or aspirin","volume":"157","author":"Moayyedi","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jamda.2020.09.046_bib28","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1111\/jgs.14956","article-title":"Proton pump inhibitors and risk of mild cognitive impairment and dementia","volume":"65","author":"Goldstein","year":"2017","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2020.09.046_bib29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/jgs.15073","article-title":"Proton pump inhibitor use and dementia risk: Prospective population-based study","volume":"66","author":"Gray","year":"2018","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2020.09.046_bib30","doi-asserted-by":"crossref","first-page":"e14422","DOI":"10.1097\/MD.0000000000014422","article-title":"Proton pump inhibitor use and risk of dementia","volume":"98","author":"Li","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.jamda.2020.09.046_bib31","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/jgs.14813","article-title":"Association of proton pump inhibitors usage with risk of pneumonia in dementia patients","volume":"65","author":"Ho","year":"2017","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2020.09.046_bib32","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/2042098617715381","article-title":"Adverse effects proton pump inhibitor use in older adults: a review of the evidence","volume":"819","author":"Maes","year":"2017","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.jamda.2020.09.046_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12872-016-0453-6","article-title":"Is the concomitant use of clopidogrel and proton pump inhibitors still associated with increased adverse cardiovascular outcomes following coronary angioplasty? A systematic review and meta-analysis of recently published studies (2012\u20132016)","volume":"17","author":"Bundhun","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jamda.2020.09.046_bib34","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.3389\/fphys.2018.01550","article-title":"PPIs are not responsible for elevating cardiovascular risk in patients on clopidogrel \u2013 a systematic review and meta-analysis","volume":"9","author":"Demcsak","year":"2018","journal-title":"Front Physiol"},{"key":"10.1016\/j.jamda.2020.09.046_bib35","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/jgs.15385","article-title":"Proton-pump inhibitors and long-term risk of community-acquired pneumonia in older adults","volume":"66","author":"Zirk-Sadowski","year":"2018","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2020.09.046_bib36","doi-asserted-by":"crossref","first-page":"e0204231","DOI":"10.1371\/journal.pone.0204231","article-title":"Duration and\u00a0dosing of proton pump inhibitors associated with high incidence of chronic kidney disease in population-based cohort","volume":"13","author":"Rodriguez-Ponceleas","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jamda.2020.09.046_bib37","doi-asserted-by":"crossref","first-page":"I1580","DOI":"10.1136\/bmj.l1580","article-title":"Estimates of all cause mortality and cause specific mortality associated with proton pump inhibitors among US Veterans: cohort study","volume":"365","author":"Xie","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jamda.2020.09.046_bib38","doi-asserted-by":"crossref","first-page":"100204","DOI":"10.1016\/j.bonr.2019.100204","article-title":"Higher dose but no low dose proton pump inhibitors are associated with increased risk of subsequent hip fractures after first hip fracture: A nationwide observational cohort study","volume":"10","author":"Brozek","year":"2019","journal-title":"Bone Rep"},{"key":"10.1016\/j.jamda.2020.09.046_bib39","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.3390\/ijerph16091571","article-title":"Proton pump inhibitors and fracture risk: A review of current evidence and mechanisms involved","volume":"16","author":"Thong","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jamda.2020.09.046_bib40","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/gutjnl-2020-322248","article-title":"Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: A nationwide cohort study with propensity score matching","volume":"70","author":"Lee","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.jamda.2020.09.046_bib41","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jamda.2013.01.021","article-title":"Use of proton pump inhibitors with lack of diagnostic indications in 22 Midwestern US skilled nursing facilities","volume":"14","author":"Burdsall","year":"2013","journal-title":"J\u00a0Am Med Dir Assn"},{"key":"10.1016\/j.jamda.2020.09.046_bib42","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1111\/jgs.13066","article-title":"Gastroprotective agent underuse in high-risk older daily non-steroidal anti-inflammatory drug users over time","volume":"62","author":"Marcum","year":"2014","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2020.09.046_bib43","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jamda.2007.07.001","article-title":"Use of proton pump inhibitors and other acid suppressive medications in newly admitted nursing facility patients","volume":"8","author":"Glew","year":"2007","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2020.09.046_bib44","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/8755122515575177","article-title":"Review of proton pump inhibitor overuse in the US Veteran population","volume":"31","author":"Metaxas","year":"2015","journal-title":"J\u00a0Pharmacy Technol"},{"key":"10.1016\/j.jamda.2020.09.046_bib45","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1111\/bcp.13258","article-title":"Comparing intravenous and oral proton pump inhibitor therapy for bleeding peptic ulcers following endoscopic management: a systematic review and meta-analysis","volume":"83","author":"Tringali","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jamda.2020.09.046_bib46","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1111\/j.1532-5415.2011.03545.x","article-title":"Proton pump inhibitor discontinuation in long-term care","volume":"59","author":"Linsky","year":"2011","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2020.09.046_bib47","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1111\/jgs.15079","article-title":"Older adults\u2019 awareness of deprescribing: A population-based survey","volume":"65","author":"Turner","year":"2017","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2020.09.046_bib48","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jamda.2019.08.031","article-title":"Deprescribing as a clinical improvement focus","volume":"21","author":"Dharmarajan","year":"2020","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2020.09.046_bib49","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/bmjqs-2019-009897","article-title":"Passing the acid test? Evaluating the impact of national education initiatives to reduce proton pump inhibitor use in Australia","volume":"29","author":"Bruno","year":"2020","journal-title":"BMJ Qual Saf"},{"key":"10.1016\/j.jamda.2020.09.046_bib50","doi-asserted-by":"crossref","first-page":"182","DOI":"10.5056\/jnm18001","article-title":"Advantages and disadvantages of long-term proton pump inhibitor use","volume":"24","author":"Kinoshita","year":"2018","journal-title":"J\u00a0Neurogastroenterol Motil"},{"key":"10.1016\/j.jamda.2020.09.046_bib51","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1053\/j.gastro.2019.09.053","article-title":"What is the optimal follow-up time to ascertain the safety of proton pump inhibitors?","volume":"158","author":"Losurdo","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jamda.2020.09.046_bib52","doi-asserted-by":"crossref","first-page":"e0124653","DOI":"10.1371\/journal.pone.0124653","article-title":"Proton pump inhibitors usage and the risk of myocardial infarction in the general population","volume":"10","author":"Shah","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jamda.2020.09.046_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1756284819834511","article-title":"Long-term use of proton pump inhibitors and risk of gastric cancer: A review of the current evidence","volume":"12","author":"Cheung","year":"2019","journal-title":"Ther Adv Gastroenterol"},{"key":"10.1016\/j.jamda.2020.09.046_bib54","first-page":"477","article-title":"The indications, applications, and risks of proton pump inhibitors","volume":"113","author":"Mossner","year":"2016","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.jamda.2020.09.046_bib56","first-page":"258","article-title":"Optimizing prescribing and deprescribing of proton pump inhibitors","volume":"16","author":"Wills","year":"2020","journal-title":"J\u00a0Nurs Pract"},{"key":"10.1016\/j.jamda.2020.09.046_bib57","doi-asserted-by":"crossref","first-page":"305","DOI":"10.14740\/gr1238","article-title":"Educational intervention improves proton pump inhibitor stewardship in outpatient gastroenterology clinics","volume":"12","author":"Walker","year":"2019","journal-title":"Gastroenterol Res"},{"key":"10.1016\/j.jamda.2020.09.046_bib58","first-page":"354","article-title":"Deprescribing proton pump inhibitors. Evidence-based clinical practice guideline","volume":"63","author":"Farrell","year":"2017","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.jamda.2020.09.046_bib59","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1186\/s12913-018-3358-5","article-title":"Changes in proton pump inhibitor prescribing trend over the past decade and pharmacists\u2019 effect on prescribing practice at a tertiary hospital","volume":"18","author":"Luo","year":"2018","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jamda.2020.09.046_bib60","doi-asserted-by":"crossref","first-page":"673.e1","DOI":"10.1016\/j.jamda.2016.04.020","article-title":"Effect of a proton pump inhibitor deprescribing guideline on drug usage and costs in long-term care","volume":"17","author":"Thompson","year":"2016","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2020.09.046_bib61","doi-asserted-by":"crossref","first-page":"5469","DOI":"10.3390\/ijms20215469","article-title":"Problems associated with deprescribing of proton pump inhibitors","volume":"20","author":"Helgadottir","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jamda.2020.09.046_bib62","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/jamainternmed.2020.0040","article-title":"Deprescribing proton pump inhibitors. Overcoming resistance","volume":"180","author":"Lee","year":"2020","journal-title":"JAMA Intern Med"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861020309890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861020309890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:23:51Z","timestamp":1761506631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861020309890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1525861020309890"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2020.09.046","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Use and Misuse of Proton Pump Inhibitors: An Opportunity for Deprescribing","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2020.09.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 AMDA - The Society for Post-Acute and Long-Term Care Medicine.","name":"copyright","label":"Copyright"}]}}